Serotonin (5-HT) transporters (SERTs) are critical determinants of synaptic 5HT availability in the CMS and periphery and major targets for antidepressants and psychostimulants including cocaine and MDMA. Endogenous mechanisms that modulate SERT activity are emerging, but as yet remain ill defined. Past studies have identified SERTs as phosphoproteins, regulated acutely (minutes) by multiple signaling pathways that influence transporter trafficking and intrinsic activity. In the current proposal, we continue our investigations of SERT regulation, bridging heterologous model systems with studies using in vitro and in vivo studies of native preparations.
In Specific Aim I we evaluate the role of protein kinase G (PKG)-linked signaling pathways in modulation of SERT trafficking and SERT protein/protein interactions as downstream consequences of GPCR activation in vitro and in vivo. Preliminary studies here reveal PKG-dependent changes in SERT surface density, 5-HT uptake, SERT currents and 5-HT clearance in vivo and support a direct role for SERT phosphorylation in GPCR/PKG linked modulation.
In Specific Aim II, we examine the role of p38 mitogen associated protein kinase (MAPK) in modulating SERT intrinsic activities. Preliminary studies here provide evidence for catalytic modulation of SERT targeting surface transporters, dependent on PP2A function for p38 MAPK regulation, and the ability of p38 MAPK to directly phosphorylate SERT.
In specific aim III, we investigate the degree to which basal and PKC/PKG/p38 MAPK-mediated alterations in SERT activity are evident in human SERT coding polymorphisms. Preliminary findings on this Aim reveal the existence of multiple SERT alleles that display altered kinase-mediated regulation, alleles that may be enriched in populations at risk for 5-HT linked disorders and which offer novel opportunities for insights into molecular mechanisms of SERT regulation/therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA007390-18
Application #
7391560
Study Section
Neurotransporters, Receptors, and Calcium Signaling Study Section (NTRC)
Program Officer
Pilotte, Nancy S
Project Start
1994-08-01
Project End
2010-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
18
Fiscal Year
2008
Total Cost
$509,738
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Mergy, Marc A; Gowrishankar, Raajaram; Davis, Gwynne L et al. (2014) Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder. Neurochem Int 73:56-70
Ye, R; Carneiro, A M D; Airey, D et al. (2014) Evaluation of heritable determinants of blood and brain serotonin homeostasis using recombinant inbred mice. Genes Brain Behav 13:247-60
Moritz, Amy E; Foster, James D; Gorentla, Balachandra K et al. (2013) Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding. J Biol Chem 288:20-32
Veenstra-VanderWeele, Jeremy; Muller, Christopher L; Iwamoto, Hideki et al. (2012) Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A 109:5469-74
Zhu, Chong-Bin; Lindler, Kathryn M; Campbell, Nicholas G et al. (2011) Colocalization and regulated physical association of presynaptic serotonin transporters with A? adenosine receptors. Mol Pharmacol 80:458-65
Ye, R; Blakely, R D (2011) Natural and engineered coding variation in antidepressant-sensitive serotonin transporters. Neuroscience 197:28-36
Thompson, Brent J; Jessen, Tammy; Henry, L K et al. (2011) Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. Proc Natl Acad Sci U S A 108:3785-90
Kovtun, Oleg; Tomlinson, Ian D; Sakrikar, Dhananjay S et al. (2011) Visualization of the cocaine-sensitive dopamine transporter with ligand-conjugated quantum dots. ACS Chem Neurosci 2:370-8
Field, Julie R; Henry, L Keith; Blakely, Randy D (2010) Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine. J Biol Chem 285:11270-80
Zhu, Chong-Bin; Lindler, Kathryn M; Owens, Anthony W et al. (2010) Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 35:2510-20

Showing the most recent 10 out of 73 publications